Navigation Links
Stater Bros. Super Rx Pharmacies Offer Free Antibiotics
Date:9/30/2009

SAN BERNARDINO, Calif., Sept. 29 /PRNewswire/ -- During these challenging economic times, Stater Bros. Supermarkets remain committed to the health and well-being of its customers. Beginning September 30, all 28 conveniently located Stater Bros. Super Rx Pharmacies throughout Southern California will offer a free 14-day supply of selected antibiotics, including refills, to anyone with or without health insurance coverage who presents a prescription.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030421/STATERLOGO)

Eight different classes of antibiotics are available, which include:

  • Amoxil (Generic for AMOXIL)
  • Ampicillin
  • Ciprofloxacin (Generic for CIPRO)
  • Doxycycline
  • Erythromycin
  • Penicillin
  • Trimeth/Sulfa (Generic for SEPTRA OR BACTRIM)
  • Tetracycline

"Stater Bros. realizes that the current economic environment coupled with climbing health insurance rates have made access to crucial medication difficult for many of our customers," stated Jack H. Brown, Stater Bros. Chairman and CEO. "As the only Supermarket Chain in Southern California to offer this program free of charge, Stater Bros. is doing all that we can to ensure accessible and affordable health care to our valued customers."

Stater Bros. is also committed to affordable health care through the Company's $4 Generic Prescription Program. Over 300 commonly prescribed medications are $4 for a 30 day supply or $10 for a 90 day supply.

Stater Bros. was founded in 1936 in Yucaipa, California, and has grown steadily through the years to become the largest privately owned Supermarket Chain in Southern California and the largest private employer in both San Bernardino County and Riverside County, with annual sales in 2008 of $3.74 billion. Last year, Stater Bros. contributed over $15 million in support of nonprofit organizations in the communities it serves, with an emphasis on worthy programs that benefit hunger relief, health and nutrition, and education. The Company currently operates 167 Supermarkets, and there are over 19,000 members of the Stater Bros. "Family" of Employees.

STATER BROS. MARKETS...SERVING SOUTHERN CALIFORNIA FAMILIES FOR OVER 73 YEARS

    Contact:
    Susan Atkinson
    Vice President Corporate Affairs
    Stater Bros. Markets
    (909) 733-5038

SOURCE Stater Bros.


'/>"/>
Stater Bros.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbotts XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
2. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
3. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
4. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
5. Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
6. Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment
7. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
8. Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
9. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
10. Chemstar Corporation Offers Comprehensive Deep Cleaning Programs to Combat Salmonella, Listeria, and E. coli in Retail Supermarkets
11. SuperGens PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... Louis, Missouri (PRWEB) , ... May 26, 2016 ... ... cost, quality and clinical outcomes, hosted members and suppliers for its inaugural Member ... a focus on their mission of elevating the operational health of America’s healthcare ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... that has a significant negative impact on long-term patient survival, reports a team ... results, published online this week in the Journal of Thoracic and Cardiovascular Surgery, ...
(Date:5/26/2016)... ... , ... An April Gallup survey found rising health care costs to be ... Health Senior Living (SHSL) may not share those same worries thanks to a ... the year, while holding the line on increasing their contributions, including premiums, deductibles and ...
(Date:5/26/2016)... , ... May 26, 2016 , ... The Lung ... host a six-week smoking cessation class starting June 6 at their clinic in downtown ... http://www.gnahec.org . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
Breaking Medicine News(10 mins):